Large inoperable leiomyosarcoma of the prostate: treated by transcatheter arterial chemoembolization with drug-eluting microspheres

BACKGROUND: Prostatic leiomyosarcoma (LMS) has a poor prognosis with a median overall survival (OS) of 15–18 months. For patients with metastatic disease, radical surgical resection, with or without adjuvant systemic chemotherapy and radiation therapy, unfortunately provides limited therapeutic bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mao Qiang, Zhang, Jin Long, Yuan, Kai, Yuan, Bing, Duan, Feng, Yan, Jie Yu, Wang, Yan, Fu, Jin Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238308/
https://www.ncbi.nlm.nih.gov/pubmed/32489428
http://dx.doi.org/10.1177/1758835920917573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238308/
https://www.ncbi.nlm.nih.gov/pubmed/32489428
http://dx.doi.org/10.1177/1758835920917573

Ejemplares similares